Advantage Capital Partners — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
MedRhythms develops digital therapeutics using music, sensors, and software combined with neuroscience to improve walking and mobility in patients with neurological conditions including stroke, multiple sclerosis, and Parkinson's disease.
AI & Machine LearningDigital HealthMedical DevicesBoston, US
Brian Harris(Co-Founder and CEO)inOwen McCarthy(Executive Officer, Director)inRaymond Pawlicki(Director)Musan Duric(Director)
BoardWilliam McKee(Director)Isaac Cheng(Director)
Co-investorsBose VenturesCEI VenturesGlobal BrainPeterson VenturesMaine Venture Fund
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




